Lidoderm Buyers Fight Dismissal Bid In Pay-For-Delay Suit
Consumers and others who bought Lidoderm pain patches hit back Monday at a bid by Endo Pharmaceuticals Inc. and other drugmakers to dismiss multidistrict litigation accusing them of using a patent...To view the full article, register now.
Already a subscriber? Click here to view full article